Denosumab osteoporosis drug

Denosumab osteoporosis drug

C028/4458 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 50.1MB

Downloadable file size: 8.4MB

Price image Pricing

Please login to use the price calculator


Credit: DR P. MARAZZI/SCIENCE PHOTO LIBRARY

Restrictions: Editorial use only Not to be shared on social media or embedded in a web page without permission.

Caption: Denosumab osteoporosis drug. Nurse holding a syringe containing the monoclonal antibody drug denosumab, marketed under the name Prolia. Denosumab is used to treat osteoporosis, treatment-induced bone loss, metastatic bone cancer, and giant cell tumour of bone.

Release details: Model release not required. Property release not required.

Keywords: adult, antibodies, bone disease, bone loss, brand, branded, caucasian, close-up, condition, denosumab, detail, device, disease, diseases, disorder, drug, drugs, equipment, female, giant cell tumour, healthcare, holding, human, igg, immunoglobulin, injection, medical, medicine, metastases, metastatic bone cancer, monoclonal antibody, nurse, osteoporosis, people, person, pharmaceutical, pharmaceutics, pharmacological, pharmacology, prescribed, prescription, product, prolia, syringe, treatment, treatment-induced, tumor, white, woman

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.